{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:40:20Z","timestamp":1793932820630,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011513","name":"Ataxia Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bbr.2022.114107","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:36:07Z","timestamp":1662636967000},"page":"114107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A promising mouse model for Friedreich Ataxia progressing like human patients"],"prefix":"10.1016","volume":"436","author":[{"given":"Catherine","family":"G\u00e9rard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle Fortin","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques P.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbr.2022.114107_bib1","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/ijms22041815","article-title":"Future prospects of gene therapy for Friedreich\u2019s ataxia","volume":"22","author":"Ocana-Santero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2022.114107_bib2","article-title":"Molecular approaches for the treatment and prevention of Friedreich's ataxia","author":"Yang","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.bbr.2022.114107_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ppedcard.2011.02.007","article-title":"The heart in Friedreich's ataxia: basic findings and clinical implications","volume":"31","author":"Payne","year":"2011","journal-title":"Prog. Pediatr. Cardiol."},{"issue":"5","key":"10.1016\/j.bbr.2022.114107_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbr.2022.114107_bib5","first-page":"1","article-title":"Friedreich Ataxia: current status and future prospects","volume":"4","author":"B\u00fcrk","year":"2017","journal-title":"Cereb. Ataxias"},{"issue":"4","key":"10.1016\/j.bbr.2022.114107_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s13311-019-00764-x","article-title":"Molecular mechanisms and therapeutics for the GAA\u00b7TTC expansion disease Friedreich ataxia","volume":"16","author":"Gottesfeld","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2022.114107_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/JMDH.S292945","article-title":"Friedreich ataxia: multidisciplinary clinical care","volume":"14","author":"Lynch","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.bbr.2022.114107_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuro.2021.11.003","article-title":"Mitochondrial iron metabolism and neurodegenerative diseases","volume":"88","author":"Cheng","year":"2022","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2022.114107_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mito.2021.10.004","article-title":"Mitochondrial iron-sulfur cluster biogenesis and neurological disorders","volume":"62","author":"Selvanathan","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbr.2022.114107_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jnc.12219","article-title":"Animal and cellular models of Friedreich ataxia","volume":"126","author":"Perdomini","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2022.114107_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2015.03.001","article-title":"Sensorimotor skills in Fxn KO\/Mck mutants deficient for frataxin in muscle","volume":"1608","author":"Filali","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2022.114107_bib12","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.1038\/mtm.2014.44","article-title":"An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models","volume":"1","author":"G\u00e9rard","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.bbr.2022.114107_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bbr.2022.114107_bib14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","article-title":"Rapid and complete reversal of sensory ataxia by gene therapy in a novel model of Friedreich ataxia","volume":"26","author":"Piguet","year":"2018","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bbr.2022.114107_bib15","first-page":"225","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich\u2019s ataxia","volume":"8","author":"Anjomani Virmouni","year":"2015","journal-title":"Dis. Models Mech."},{"issue":"9","key":"10.1016\/j.bbr.2022.114107_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107416","article-title":"Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia","volume":"9","author":"Anjomani Virmouni","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbr.2022.114107_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/gt.2016.36","article-title":"Development of an AAV9 coding for a 3XFLAG-TALEfrat# 8-VP64 able to increase in vivo the human frataxin in YG8R mice","volume":"23","author":"Chapdelaine","year":"2016","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.bbr.2022.114107_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/gt.2016.89","article-title":"Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia","volume":"24","author":"Ouellet","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbr.2022.114107_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.omtn.2018.04.009","article-title":"Increased frataxin expression induced in Friedreich ataxia cells by platinum TALE-VP64s or platinum TALE-SunTag","volume":"12","author":"Cherif","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.bbr.2022.114107_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.bbr.2022.114107_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis","volume":"3","author":"Pook","year":"2001","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.bbr.2022.114107_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nprot.2007.19","article-title":"The parallel rod floor test: a measure of ataxia in mice","volume":"2","author":"Kamens","year":"2007","journal-title":"Nat. Protoc."},{"issue":"76","key":"10.1016\/j.bbr.2022.114107_bib23","article-title":"Measuring the strength of mice","author":"Deacon","year":"2013","journal-title":"JoVE J. Vis. Exp."},{"issue":"6","key":"10.1016\/j.bbr.2022.114107_bib24","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0096-15.2015","article-title":"Loss of projections, functional compensation, and residual deficits in the mammalian vestibulospinal system of Hoxb1-deficient mice.","volume":"2","author":"Di Bonito","year":"2015","journal-title":"ENeuro"},{"issue":"49","key":"10.1016\/j.bbr.2022.114107_bib25","article-title":"Assessment of motor balance and coordination in mice using the balance beam","author":"Luong","year":"2011","journal-title":"JoVE J. Vis. Exp."},{"key":"10.1016\/j.bbr.2022.114107_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30054","article-title":"Inducible and reversible phenotypes in a novel mouse model of Friedreich\u2019s Ataxia","volume":"6","author":"Chandran","year":"2017","journal-title":"Elife"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2022.114107_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbr.2022.114107_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20732","article-title":"Loss of Frataxin activates the iron\/sphingolipid\/PDK1\/Mef2 pathway in mammals","volume":"5","author":"Chen","year":"2016","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.bbr.2022.114107_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-021-04100-5","article-title":"Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations","volume":"79","author":"Medina-Carbonero","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbr.2022.114107_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2016.08.053","article-title":"Neurobehavioral deficits in the KIKO mouse model of Friedreich\u2019s ataxia","volume":"316","author":"McMackin","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"15\u201316","key":"10.1016\/j.bbr.2022.114107_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/hum.2019.363","article-title":"Stress-induced mouse model of the cardiac manifestations of Friedreich's ataxia corrected by AAV-mediated gene therapy","volume":"31","author":"Salami","year":"2020","journal-title":"Hum. Gene Ther."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822003758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822003758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:37:46Z","timestamp":1759066666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432822003758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"alternative-id":["S0166432822003758"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2022.114107","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A promising mouse model for Friedreich Ataxia progressing like human patients","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2022.114107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114107"}}